Analyzing Auna (NYSE:AUNA) & Progyny (NASDAQ:PGNY)

Progyny (NASDAQ:PGNYGet Free Report) and Auna (NYSE:AUNAGet Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Profitability

This table compares Progyny and Auna’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Progyny 4.46% 10.71% 7.27%
Auna 4.40% 13.52% 3.27%

Analyst Ratings

This is a summary of current ratings and recommmendations for Progyny and Auna, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny 0 3 9 1 2.85
Auna 1 2 2 1 2.50

Progyny presently has a consensus target price of $29.36, suggesting a potential upside of 19.70%. Auna has a consensus target price of $7.30, suggesting a potential upside of 37.48%. Given Auna’s higher probable upside, analysts plainly believe Auna is more favorable than Progyny.

Valuation and Earnings

This table compares Progyny and Auna”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Progyny $1.17 billion 1.81 $54.34 million $0.63 38.94
Auna $1.17 billion 0.34 $29.39 million $0.71 7.48

Progyny has higher earnings, but lower revenue than Auna. Auna is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Progyny has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Auna has a beta of 2.26, suggesting that its share price is 126% more volatile than the S&P 500.

Institutional & Insider Ownership

94.9% of Progyny shares are held by institutional investors. 9.4% of Progyny shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Progyny beats Auna on 9 of the 14 factors compared between the two stocks.

About Progyny

(Get Free Report)

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

About Auna

(Get Free Report)

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.